June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Neurokinin 1 Receptor Antagonist: a Novel Analgesic for Pain following Corneal Alkali Burn
Author Affiliations & Notes
  • Hideaki Someya
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Amirreza Naderi
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Aytan Musayeva
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Shudan Wang
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Francesca Kahale
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Akitomo Narimatsu
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Yihe Chen
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Reza Dana
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Hideaki Someya None; Amirreza Naderi None; Aytan Musayeva None; Shudan Wang None; Francesca Kahale None; Akitomo Narimatsu None; Yihe Chen Massachusetts Eye and Ear, Code P (Patent); Reza Dana Massachusetts Eye and Ear, Code P (Patent)
  • Footnotes
    Support  W81XWH-21-1-0839
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 718. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hideaki Someya, Amirreza Naderi, Aytan Musayeva, Shudan Wang, Francesca Kahale, Akitomo Narimatsu, Yihe Chen, Reza Dana; Neurokinin 1 Receptor Antagonist: a Novel Analgesic for Pain following Corneal Alkali Burn. Invest. Ophthalmol. Vis. Sci. 2023;64(8):718.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Substance P (SP) is a well-known modulator of pain and has been shown to modulate nociception in the murine cornea. The purpose of this study was to determine whether the inhibition of SP can reduce ocular pain following corneal chemical injury by local antagonism of SP’s preferred receptor, neurokinin 1 receptor (NK1R).

Methods : Corneal alkali burn was induced in C57BL/6 mice by placing a paper disc (2-mm diameter) soaked in 1 N NaOH for 10 seconds on the central cornea. 6 mice with 1:1 sex ratio were used for each experiment. SP protein levels in the cornea and trigeminal ganglion (TG) were measured by ELISA at 4, 7, 14, 21, and 28 days after alkali burn induction. Animals were randomized into two groups receiving L-733,060 (1μg/μl) or PBS, topically twice a day for 4 weeks after alkali burn. On day 4, 7, 14, 21 and 28, eye wiping test (EWT) was performed to evaluate hyperalgesia after applying hypertonic saline (2M NaCl) as noxious stimulus. Following EWT, allodynia was assessed by quantifying palpebral ratio (PR) via an automated video analysis of the animals’ eye after instillation of a saline solution iso-osmolar to tears (0.9 % NaCl) as innocuous stimulus.

Results : The SP levels in the corneas at 4, 7, 14, 21, and 28 days after alkali burn were 9465 ± 1625, 12721 ± 2088, 12536 ± 831, 12476 ± 3402, and 11145 ± 647 pg/mg, respectively. Compared with the SP level of naive corneas (8155 ± 483 pg/mg), there were significant increases in the SP levels of the corneas on days 7, 14, 21, and 28 after alkali burn (P<0.001, P< 0.001, P<0.001, P<0.01, respectively). Meanwhile, the SP levels in TG had no significant change at any time point after alkali burn. Eye wipe behavior was significantly higher in PBS group compared to normal mice at all time points after alkali burn. L-733,060 group showed significant decreases in the behavior compared to PBS group at day 4, 14, 21, 28 (P < 0.01, P < 0.01, P < 0.01, P < 0.05, respectively). Similarly, PR was significantly lower in PBS group compared to normal mice at all time points after alkali burn. L-733,060 group showed significant increases in PR at day 4, 14, 21, 28 (P < 0.01, P < 0.05, P < 0.01, P < 0.05, respectively).

Conclusions : Our data demonstrate that NK1R antagonist reduces ocular pain in the murine alkali burn model.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×